Your browser doesn't support javascript.
loading
Protein networking: nicotinic acetylcholine receptors and their protein-protein-associations.
Brockmöller, Sabrina; Worek, Franz; Rothmiller, Simone.
Afiliação
  • Brockmöller S; Bundeswehr Institute of Pharmacology and Toxicology, Munich, Bavaria, Germany. Sabrina.Brockmoeller@yahoo.de.
  • Worek F; Bundeswehr Institute of Pharmacology and Toxicology, Munich, Bavaria, Germany.
  • Rothmiller S; Bundeswehr Institute of Pharmacology and Toxicology, Munich, Bavaria, Germany.
Mol Cell Biochem ; 479(7): 1627-1642, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38771378
ABSTRACT
Nicotinic acetylcholine receptors (nAChR) are complex transmembrane proteins involved in neurotransmission in the nervous system and at the neuromuscular junction. nAChR disorders may lead to severe, potentially fatal pathophysiological states. To date, the receptor has been the focus of basic and applied research to provide novel therapeutic interventions. Since most studies have investigated only the nAChR itself, it is necessary to consider the receptor as part of its protein network to understand or elucidate-specific pathways. On its way through the secretory pathway, the receptor interacts with several chaperones and proteins. This review takes a closer look at these molecular interactions and focuses especially on endoplasmic reticulum biogenesis, secretory pathway sorting, Golgi maturation, plasma membrane presentation, retrograde internalization, and recycling. Additional knowledge regarding the nAChR protein network may lead to a more detailed comprehension of the fundamental pathomechanisms of diseases or may lead to the discovery of novel therapeutic drug targets.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores Nicotínicos Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores Nicotínicos Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article